Furthermore, the CD40-CD40L (CD154) pathway is vital for enhancing the adaptive immune response to TB (31), and all vaccine candidates showed significantly increased CD154 expression on the surface of CD4+T cells (Figure 4C). Here, CD4 is linked to tuberculosis.